Association between MYC rs9642880[T] allele and bladder cancer risk: A meta-analysis

Genetics and Molecular Research

Volumn 14, Issue 4, 2015, Pages 14745-14751

  Zhao, Y ^a   Qi, J G ^a   Yang, N ^a   Lin, Y L ^a   Liang, J ^a   Zhu, X ^b  

^a AFFILIATED HOSPITAL OF JIANGSU UNIVERSITY   (China)

^b SUZHOU MUNICIPAL HOSPITAL   (China)

Author keywords

Bladder cancer; Meta analysis; MYC; Rs9642880 T allele

Indexed keywords

ALLELE; ARTICLE; ASIAN; BLADDER CANCER; CANCER RISK; CANCER SUSCEPTIBILITY; DATA EXTRACTION; ETHNIC DIFFERENCE; EUROPEAN; GENE LOCUS; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENOTYPE ENVIRONMENT INTERACTION; HUMAN; MEDICAL LITERATURE; ONCOGENE MYC; PUBLISHING; QUANTITATIVE ANALYSIS; SENSITIVITY ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM; STUDY DESIGN; BLADDER TUMOR; GENETIC ASSOCIATION STUDY; GENETIC PREDISPOSITION; GENETICS; GENOTYPE; META ANALYSIS; PATHOLOGY; RISK FACTOR;

MYC PROTEIN; MYC PROTEIN, HUMAN;

ALLELES; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTO-ONCOGENE PROTEINS C-MYC; RISK FACTORS; URINARY BLADDER NEOPLASMS;

EID: 84948161931     PISSN: None     EISSN: 16765680     Source Type: Journal    
DOI: 10.4238/2015.November.18.39     Document Type: Article

References (27)

1. Anso E, Mullen AR, Felsher DW, Matés JM, et al. (2013). Metabolic changes in cancer cells upon suppression of MYC. Cancer Metab. 1: 7.
2. Chang DW, Gu J and Wu X (2012). Germline prognostic markers for urinary bladder cancer: obstacles and opportunities. Urol. Oncol. 30: 524-532.
3. DePinho RA, Schreiber-Agus N and Alt FW (1991). myc family oncogenes in the development of normal and neoplastic cells. Adv. Cancer Res. 57: 1-46.
4. DerSimonian R and Laird N (1986). Meta-analysis in clinical trials. Control Clin. Trials 7: 177-188.
5. Easton DF, Pooley KA, Dunning AM, Pharoah PD, et al. (2007). Genome-wide association study identifies novel breast cancer susceptibility loci. Nature 447: 1087-1093.
6. Egger M, Davey Smith G, Schneider M and Minder C (1997). Bias in meta-analysis detected by a simple, graphical test. BMJ 315: 629-634.
7. Fernandez PC, Frank SR, Wang L, Schroeder M, et al. (2003). Genomic targets of the human c-Myc protein. Genes Dev. 17: 1115-1129.
8. Golka K, Hermes M, Selinski S, Blaszkewicz M, et al. (2009). Susceptibility to urinary bladder cancer: relevance of rs9642880[T], GSTM1 0/0 and occupational exposure. Pharmacogenet. Genomics 19: 903-906.
9. Golka K, Selinski S, Lehmann ML, Blaszkewicz M, et al. (2011). Genetic variants in urinary bladder cancer: collective power of the “wimp SNPs”. Arch. Toxicol. 85: 539-554.
10. Gudmundsson J, Sulem P, Manolescu A, Amundadottir LT, et al. (2007). Genome-wide association study identifies a second prostate cancer susceptibility variant at 8q24. Nat. Genet. 39: 631-637.
11. Handoll HH (2006). Systematic reviews on rehabilitation interventions. Arch. Phys. Med. Rehabil. 87: 875.
12. Jemal A, Bray F, Center MM, Ferlay J, et al. (2011). Global cancer statistics. CA Cancer J. Clin. 61: 69-90.
13. Kiemeney LA, Thorlacius S, Sulem P, Geller F, et al. (2008). Sequence variant on 8q24 confers susceptibility to urinary bladder cancer. Nat. Genet. 40: 1307-1312.
14. Mantel N and Haenszel W (1959). Statistical aspects of the analysis of data from retrospective studies of disease. J. Natl. Cancer Inst. 22: 719-748.
15. Nilsson JA and Cleveland JL (2003). Myc pathways provoking cell suicide and cancer. Oncogene 22: 9007-9021.
16. Pharoah PD, Dunning AM, Ponder BA and Easton DF (2004). Association studies for finding cancer-susceptibility genetic variants. Nat. Rev. Cancer 4: 850-860.
17. Sauter G, Carroll P, Moch H, Kallioniemi A, et al. (1995). c-myc copy number gains in bladder cancer detected by fluorescence in situ hybridization. Am. J. Pathol. 146: 1131-1139.
18. Schwender H, Selinski S, Blaszkewicz M, Marchan R, et al. (2012). Distinct SNP combinations confer susceptibility to urinary bladder cancer in smokers and non-smokers. PLoS One 7: e51880.
19. Terunuma A, Putluri N, Mishra P, Mathé EA, et al. (2014). MYC-driven accumulation of 2-hydroxyglutarate is associated with breast cancer prognosis. J. Clin. Invest. 124: 398-412.
20. Wang M, Wang M, Zhang W, Yuan L, et al. (2009). Common genetic variants on 8q24 contribute to susceptibility to bladder cancer in a Chinese population. Carcinogenesis 30: 991-996.
21. Wang M, Chu H, Lv Q, Wang L, Yuan L, et al. (2014a). Cumulative effect of genome-wide association study-identified genetic variants for bladder cancer. Int. J. Cancer 135: 2653-2660.
22. Wang P, Ye D, Guo J, Liu F, et al. (2014b). Genetic score of multiple risk-associated single nucleotide polymorphisms is a marker for genetic susceptibility to bladder cancer. Genes Chromosomes Cancer 53: 98-105.
23. Wood RD, Mitchell M and Lindahl T (2005). Human DNA repair genes, 2005. Mutat. Res. 577: 275-283.
24. Wu X, Ye Y, Kiemeney LA, Sulem P, et al. (2009). Genetic variation in the prostate stem cell antigen gene PSCA confers susceptibility to urinary bladder cancer. Nat. Genet. 41: 991-995.
25. Yates DR, Rouprêt M, Drouin SJ, Audouin M, et al. (2013). Genetic polymorphisms on 8q24.1 and 4p16.3 are not linked with urothelial carcinoma of the bladder in contrast to their association with aggressive upper urinary tract tumours. World J. Urol. 31: 53-59.
26. Zanke BW, Greenwood CM, Rangrej J, Kustra R, et al. (2007). Genome-wide association scan identifies a colorectal cancer susceptibility locus on chromosome 8q24. Nat. Genet. 39: 989-994.
27. Zhang C, Zhang S, Zhang Z, et al. (2014). MYC-driven accumulation of 2-hydroxyglutarate is associated with breast cancer prognosis. J. Clin. Invest. 124: 398-412.